Global Chondroitin Sulfate Market Segments 2024, Forecast To 2033
5 Mar, 2024
The chondroitin sulfate market grew steadily, rising from $1.38 billion in 2023 to $1.44 billion in 2024, with a 5.0% CAGR. Historical growth is linked to an aging population, joint health awareness, and expansion in the dietary supplement industry. Expected to grow to $1.76 billion in 2028, the forecast period highlights applications in veterinary medicine, research advances, and global lifestyle-related joint issues, with trends like sustainable sourcing and pet nutraceuticals shaping the market.
Global Chondroitin Sulfate Market Key Driver
The chondroitin sulfate market is poised for growth due to the rising incidences of osteoarthritis. Osteoarthritis is a prevalent form of arthritis causing the gradual deterioration of protective cartilage. Chondroitin sulfate proves effective in treating osteoarthritis by providing resistance to compression, maintaining structural integrity, and alleviating muscular pain. Notably, every year, osteoporosis causes around 1.5 million fractures in the United States, leading to associated costs of $19 billion. As osteoarthritis cases are expected to rise, the demand for chondroitin sulfate is set to increase.
Get A Free Sample Of The Global Chondroitin Sulfate Market ReportGlobal Chondroitin Sulfate Market Segments
The chondroitin sulfate market covered in this report is segmented –
1) By Type: Capsule Form, Tablet Form, Powder Form
2) By Source: Bovine, Swine, Poultry, Shark, Synthetic
3) By End Users: Pet Food And Veterinary Supplements, Pharmaceutical And Biotech Companies, Cosmetics And Personal Care
By Geography: The regions covered in the anti inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions.
North America was the largest region in the chondroitin sulfate market in 2023. Asia-Pacific is expected to be the fastest-growing region in the chondroitin sulfate market report during the forecast period. The regions covered in the chondroitin sulfate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Chondroitin Sulfate Industry Players
Seikagaku Corporation; Synutra Ingredients; Yantai Ruikangda Biochemical Products Co.ltd.; TSI Group Ltd.; Sioux Pharm; Summit Nutritionals International Inc.; ZPD A/S; Sino Siam Bio technique Co. Ltd.; Bio-gen Extracts Pvt. Ltd.; Hebei Sanxin industry Group Co.Ltd.; Sigma Aldrich Inc.; Fidia Farmaceutici S.p.A.; Shandong Runxin Biotechnology Co. Ltd.; Gnosis S.p.A.; Pacific Rainbow International Inc.; Bioiberica S.A.U.; Merck KGaA; Ruikangda Biochemical Co. Ltd.; Guanglong Biochem Co. Ltd.; Nippon Zoki Pharmaceutical Co. Ltd.; Huiwen Technology Co. Ltd.; Runxin Biotechnology Co. Ltd.; Yangtze River Basin Construction Co. Ltd.; Focus Technology Co. Ltd.; SANXIN; WanTuMing Biological; QJBCHINA; Hengjie Bio-Pharmaceuticals; Rochem International Inc.; Chongqing Aoli Biopharmaceutical Co. Ltd.
Get The Full Global Chondroitin Sulfate Market Report
AIOps Chondroitin Sulfate Market Overview
Chondroitin sulfate is a chemical compound found in human and animal cartilage that is commonly used in the treatment of osteoarthritis in conjunction with other substances such as glucosamine. This condition is characterized by joint cartilage degeneration, which can be avoided by supplementing with chondroitin sulfate, which is a key component of cartilage.
Chondroitin Sulfate Global Market Report 2023 provides data on the global chondroitin sulfate market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The chondroitin sulfate market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.